Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pedro Jorge Joffily Pinto"'
Autor:
Cecília Félix Penido Mendes de Sousa, MD, Elson Santos Neto, MD, Michael Jenwei Chen, MD, Maria Letícia Gobo Silva, MD, MSc, Carolina Humeres Abrahão, MD, Henderson Ramos, MD, Ricardo Cesar Fogaroli, MD, MSc, Douglas Guedes de Castro, MD, MSc, PhD, Sérgio Leonardo Favareto, MD, Pedro Jorge Joffily Pinto, MD, Fabiana Baroni Alves Makdissi, MD, MSc, PhD, Antonio Cassio Assis Pellizzon, MD, MSc, PhD, Guilherme Rocha Melo Gondim, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 101010- (2022)
Purpose: This study aimed to evaluate the association of bolus and 2-stage breast reconstruction complications, and whether the dosimetric advantage translates into improvements in local control. Methods and Materials: We retrospectively analyzed dat
Externí odkaz:
https://doaj.org/article/a8206e1ba5a748f0a03f84ab8dc2b56d
Autor:
Wilber Edison Bernaola-Paredes, DDS, OMS, MSc, PhD, Eloah Pascuotte Filippetti, MD, Monica Lucia Rodrigues, MD, MSc, Henrique Perez Carvalho, MD, Marcelo Carvalho Coutinho, MD, Arthur Ferrari Arruda, MD, Pedro Jorge Joffily Pinto, MD, Felipe D’Almeida Costa, MD, PhD, Miriã Andrade Celestino, MD, Antonio Cassio Assis Pellizzon, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 10, Iss 7, p e4418 (2022)
Summary:. Radiation-induced head and neck sarcoma (RIHNS) is a rare and serious long-term complication of radiotherapy (RT), with poor prognosis and high morbidity and mortality. Diagnosis is based on immunohistochemistry and molecular biomarker anal
Externí odkaz:
https://doaj.org/article/6612256522c64bf58dc5ff4a46563d99
Autor:
Pedro Jorge Joffily Pinto, Michael Jenwei Chen, Elson Santos Neto, Carlos Chaves Faloppa, Louise De Brot, Andrea Paiva Gadelha Guimaraes, Alexandre Andre Balieiro Anastacio da Costa, Glauco Baiocchi
Publikováno v:
International Journal of Gynecologic Cancer. 32:239-245
ObjectiveTo evaluate the prognostic impact of clinical and pathological variables and patterns of recurrence in patients with locally advanced cervical cancer with pelvic lymph node involvement (stage IIIC1 according to the 2018 FIGO Staging System).